18
© 2014 PerkinElmer HUMAN HEALTH • ENVIRONMENTAL HEALTH Interactive Visualisation for Precision and Translational Medicine Dr. Christof Gaenzler

Interactive Visualisation for Precision and Translational

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

© 2014 PerkinElmer

HUMAN HEALTH • ENVIRONMENTAL HEALTH

Interactive Visualisation for Precision and Translational Medicine Dr. Christof Gaenzler

2

Introduction

•  Precision and Translational medicine change healthcare

•  Visual Interactive Analytics should drive decision-making

•  Customers need more complete solutions

•  Too much effort is invested in Data Collection and Curation

•  A shift towards higher value activities is needed

3

Shift Effort Towards the Higher Value Activities

4

Shift Effort Towards the Higher Value Activities

5

Shift Effort Towards the Higher Value Activities

6

Visual Information Seeking

•  Visual browsing & interacting with data •  Graphical interactive display of data •  drill-down, drill-across, filtering

•  Important in Translational Science •  Disparate datasources not designed to fit together

7

Translational Medicine Workflows

Raw Data

Select Processed Data

QA/QC Results

Review Secondary Analysis Select Clinical

Subject & Samples

Secondary Analysis

Data Processing

Select Secondary Results

Perform Integrated

Analysis

Bioinformatician/ Data Scientist Focuses on single

experiment and starts with instrument run

Translational Scientist Start with scientific hypothesis and use scientific Entities

8

Spotfire as „Query Tool“ for Selection steps

9

How does it all fit together?

Signals for Translational Combines technologies into a single solution for the translational scientist Public Data Source Connectors Leverage existing data sources with the power of the platform Signals Perspectives Adds data discovery for disparate data sets

10

PerkinElmer Signals Embedded in TIBCO™ Spotfire®

11

Visual Metadata Exploration…

12

…and Data Filtering

13

Real World Evidence across the Pharma Value Chain

•  R&D ◦  Translational, Trial Simulation & Recruitment

•  Medical & Safety

◦  AE / Signal Detection, Risk Management

•  HEOR ◦  Local Burden of disease and cost

•  Market Access

◦  Speed to market, outcomes-based pricing

•  Commercial ◦  Patient flow, Launch planning

14

RWE Use Case Specific Analysis

Kaplan-Meier Plot - also known as the product limit/

survival estimator

Forest Plot of hazard ratios by cohort

15

IHC

Multiplex ELISA

NGS

GEA

CNV and Translocations

Cohort Studies - Data Mashup: Combining Clinical and Biomarker Data

Patient Population Stratified Patient Population

Quantitative Pathology

Getting the right drug to the right patient at the right time

16

IHC

Multiplex ELISA

NGS

GEA

CNV and Translocations

Translational Medicine will become Personalized Medicine

Quantitative Pathology

Getting the right drug to the right patient at the right time

? Precise diagnosis

Targeted Therapy

17

Features of Desired Analytical Ecosystem

•  Open and Collaborative ◦  Within and between Business units ◦  Also with Vendors

•  Comprehensive ◦  Deep set of “out of the box” capabilities ◦  From data to insight

•  Flexible ◦  Exists as part of current architecture without disruption

•  Grows and changes over time!

18